HCPCS Level II code C1814 designates a silicone oil retinal tamponade device used in vitreoretinal surgery to stabilize the retina intraoperatively and postoperatively. These devices are clinically important for the management of complex retinal detachments and proliferative vitreoretinopathy, and they have implications for device supply, coding accuracy, and payer coverage nationally. Coverage and coding clarity for retinal tamponade devices affect surgical billing and hospital supply costs across payers.

Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical purpose and typical setting, an outline of common modifiers used with device and surgical billing, payer coverage patterns where available, and benchmarking context for claims and reimbursement practice. The publication also highlights coding interactions with related ophthalmic device and procedure claims and notes areas where policy updates or prior authorization requirements commonly arise.

This summary is intended for billing managers, clinical coders, surgical administrators, and policy analysts seeking a national-level reference on HCPCS Level II code C1814 and its role in vitreoretinal surgical care.